A pioneering trial in Spain will test an artificial pancreas model in 20 people with diabetes

A pioneering clinical trial in Spain, in which the Universitat Politècnica de València, the Health Research Institute (Incliva) of the Hospital Clínic of Valencia, the Clínic de Barcelona and the Higher School Polytechnic of the University of Girona (UdG) are participating in a study of  the effectiveness of an artificial pancreas, It is one of the latest advances in technology applied to health, and will be tested on 20 people with type 1 diabetes treated with CSII, ten from each hospital.
As reported by the UPV and the Incliva, the artificial pancreas is a device that is based on a mathematical control algorithm that calculates the “optimal” dose of insulin according to the needs of each individual and each moment. The idea is to provide the insulin pumps that patients with type 1 diabetes use with an additional system (control algorithm) that tells them the amount of insulin “just right and necessary for a person at any time”.
The trial is directed at the Clinic of Valencia by Dr. F. Javier Ampudia-Blasco, of the Endocrinology Service of the Clínico Universitario Hospital, in collaboration with Paolo Rossetti, of the Fransec de Borja Hospital in Gandhi, and Incliva researcher.
The essay materializes a research project that goes back to 2004, when researchers from the Institute of Automation and Industrial Computing of the UPV -Jorge Bondia- and the Institute of Computing and Applications of the University of Girona -Josep Vehí- decided to look for solutions to avoid “One of the big problems that people with diabetes still have today, which is deciding the amount of insulin needed at each moment.”
Sources: La Vanguardia / Diabetes Association of Madrid